Consensus recommendation for prenatal, neonatal and postnatal . . . Congenital cytomegalovirus (cCMV) infection carries a significant burden with a 0 64% global prevalence and a 17–20% chance of serious long-term effects in children Since the last guidelines, our understanding, particularly regarding primary maternal infections, has improved
Minimal adverse outcomes of postnatal cytomegalovirus infection in term . . . The aim of study was to investigate at what extent breastfeeding and vaginal delivery can increase mother-to-child transmission of cytomegalovirus (CMV) and to observe the clinical outcomes of postnatal infection in term or moderate and late preterm
Consensus recommendation for prenatal, neonatal and postnatal . . . Congenital cytomegalovirus (cCMV) infection carries a significant burden with a 0 64% global prevalence and a 17–20% chance of serious long-term effects in children Since the last guidelines, our understanding, particularly regarding primary maternal infections, has improved
Frontiers | Clinical presentation and transmission of postnatal . . . This study aimed to investigate the clinical presentation and transmission of postnatal CMV (pCMV) infection via breast milk in preterm infants under the specific setting of our neonatal intensive care unit (NICU)
Postnatal care for babies born with congenital cytomegalovirus (CMV) Medication – If your baby has symptoms of CMV, your baby’s doctor may recommend treatment with antiviral medication A paediatrician or an infectious diseases specialist should discuss this with you Tests that your baby may be offered Brain Imaging (Ultrasound and or MRI)
Overview of cytomegalovirus (CMV) infections in children In children, the spectrum of disease caused by CMV infection ranges from asymptomatic or mild disease in immunologically normal hosts to severe and potentially life-threatening disease in newborns and immunocompromised children (table 1)